Organicell Regenerative Medicine, Inc. OCEL
We take great care to ensure that the data presented and summarized in this overview for Organicell Regenerative Medicine, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in OCEL
Top Purchases
Top Sells
About OCEL
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.
Insider Transactions at OCEL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
1,002
+0.24%
|
$2,004
$2.27 P/Share
|
|
Jun 18
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
3,000
+0.73%
|
$6,000
$2.05 P/Share
|
|
Jun 11
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
524
+0.13%
|
$1,048
$2.0 P/Share
|
|
Jun 09
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
138
+0.03%
|
$138
$1.99 P/Share
|
|
Jun 06
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
11,100
+2.66%
|
$22,200
$2.0 P/Share
|
|
May 23
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
500
+0.13%
|
$500
$1.92 P/Share
|
|
May 21
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
3,000
+0.38%
|
$6,000
$2.09 P/Share
|
|
May 12
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
868
+0.22%
|
$1,736
$2.65 P/Share
|
|
May 09
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
1,054
+0.27%
|
$2,108
$2.66 P/Share
|
|
May 08
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
12,578
+1.08%
|
$25,156
$2.74 P/Share
|
|
May 07
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
14,459
+3.7%
|
$43,377
$3.08 P/Share
|
|
May 06
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
2,000
+0.18%
|
$6,000
$3.19 P/Share
|
|
May 05
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
30,500
+7.81%
|
$61,000
$2.88 P/Share
|
|
May 01
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
2,400
+0.72%
|
$4,800
$2.0 P/Share
|
|
Apr 30
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
949
+0.29%
|
$1,898
$2.1 P/Share
|
|
Apr 28
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
1,001
+0.31%
|
$2,002
$2.22 P/Share
|
|
Apr 23
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
175
+0.05%
|
$350
$2.05 P/Share
|
|
Apr 21
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
36
+0.01%
|
$72
$2.05 P/Share
|
|
Apr 11
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
2,400
+0.73%
|
$2,400
$1.9 P/Share
|
|
Apr 04
2025
|
Skycrest Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
1,000
+0.31%
|
$2,000
$2.35 P/Share
|
Last 12 Months Summary
| Bona fide gift | 50 shares |
|---|---|
| Open market or private purchase | 152K shares |
| Bona fide gift | 50 shares |
|---|